The global prophylactic HIV drugs market with a projected 4.1% compound annual growth rate (CAGR) between 2023 and 2033, the business is well-positioned to thrive in the future. This trajectory is expected to propel the market value from an estimated US$32,516.1 million in 2023 to a significant US$48,822.4 million by 2033, according to Future Market …